lifestyle.thriveinsider.com

Author: Indivior Inc

Indivior Announces Inclusion in the S&P SmallCap 600® Index

January 5, 2026
Indivior Announces Inclusion in the S&P SmallCap 600® Index

January 5, 2026
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations

December 23, 2025
Indivior Concludes Legacy U.S. Department of Justice Matter

November 23, 2025
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 21, 2025
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine

November 3, 2025
Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance

November 1, 2025
Indivior to Participate in the Stifel 2025 Healthcare Conference

October 29, 2025